# An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain

> **NCT00089557** · PHASE2 · TERMINATED · sponsor: **NeurogesX**

## Conditions studied

- Herpes Zoster
- Neuralgia
- Pain
- HIV Infections
- Peripheral Nervous System Diseases
- Diabetic Neuropathies
- Diabetes Mellitus
- Polyneuropathies

## Interventions

- **DRUG:** Capsaicin Dermal Patch

## Key facts

- **NCT ID:** NCT00089557
- **Lead sponsor:** NeurogesX
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00089557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00089557, "An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00089557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*